Financials

  • Market Capitalization 652.5 M
  • Employee 60
  • Founded 2019
  • CEO N/A
  • Website www.tectonictx.com
  • Headquarter New York, United States
  • FIGI BBG00DJ4T7D1
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-6.93
Price to sales ratio
-3 285.75

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2742
RGNX
REGENXBIO Inc. - Common Stock
12.41 USD-2.67%-19.62%+82.77%-7.59%641.57 M USD
2747
CRMD
CorMedix Inc. - Common Stock
8.35 USD+0.36%-5.65%-6.29%-26.11%655.07 M USD
2754
ACHV
Achieve Life Sciences, Inc. - Common Shares
6.28 USD+2.95%-2.18%+11.55%+120.35%644.70 M USD
2772
PRME
Prime Medicine, Inc. - Common Stock
3.54 USD+0.57%-10.15%+21.23%-27.01%639.39 M USD

Frequently asked questions about Tectonic Therapeutic, Inc. - Common Stock

What is the Tectonic Therapeutic, Inc. - Common Stock stock price today?

The current price of Tectonic Therapeutic, Inc. - Common Stock (TECX) is 34.58. Over the past 24 hours, the stock has changed by +0.70%. Follow the TECX chart for real-time price dynamics.

What is the stock ticker of Tectonic Therapeutic, Inc. - Common Stock?

Tectonic Therapeutic, Inc. - Common Stock trades under the ticker TECX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Tectonic Therapeutic, Inc. - Common Stock stock going up?

TECX has changed by -3.76% over the last week, +12.79% over the last month, and +101.63% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Tectonic Therapeutic, Inc. - Common Stock net income for the last quarter?

Tectonic Therapeutic, Inc. - Common Stock reported net income of -25.24 M for the last quarter. The previous quarter showed -19.23 M, which means net income changed by -31.29%.

How many employees does Tectonic Therapeutic, Inc. - Common Stock have?

As of the latest available data, Tectonic Therapeutic, Inc. - Common Stock has 60 employees. Workforce size can provide additional context about the company's scale and operations.

What is Tectonic Therapeutic, Inc. - Common Stock EBITDA?

Tectonic Therapeutic, Inc. - Common Stock EBITDA is -826 K, and its EBITDA margin is 3 591.3%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Tectonic Therapeutic, Inc. - Common Stock stock?

You can buy Tectonic Therapeutic, Inc. - Common Stock (TECX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Tectonic Therapeutic, Inc. - Common Stock stock?

Investing in Tectonic Therapeutic, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TECX chart and related analysis on metatrader.com as part of your research.